Human Factors Validation Testing of the Wandercraft Personal Exoskeleton
ExoUser
1 other identifier
interventional
14
1 country
1
Brief Summary
The goal of this interventional, national, prospective, open and monocentric study is to demonstrate that a personal exoskeleton can be used by the intended users without serious use errors or problems, for the intended uses and under the expected use conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedFirst Submitted
Initial submission to the registry
November 18, 2024
CompletedFirst Posted
Study publicly available on registry
December 4, 2024
CompletedDecember 4, 2024
December 1, 2024
2 months
November 18, 2024
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SCI user and companion performance when carrying out tasks that are critical tasks
The acceptance criterion for this test is 100% of the trained SCI users and trained companions are able to perform each of the critical task successfully during a simulated-use test.
At session 6, after an average of 7.5 hours of training.
Secondary Outcomes (4)
Use errors, close calls, and use difficulties
At session 6, after an average of 7.5 hours of training.
SCI user and companion general performance when carrying non-critical tasks
At session 6, after an average of 7.5 hours of training.
Readability and clarity of Instructions for Use (IFU)
At session 5, after an average of 6 hours of training.
SCI user and companion opinion on the accompanying documents and training
At session 6, after an average of 7.5 hours of training.
Other Outcomes (6)
SCI user and companion satisfaction and comfort
At session 6, after an average of 7.5 hours of training.
Usability of donning and doffing
At session 6, after an average of 7.5 hours of training.
Functional test with the exoskeleton
At session 6, after an average of 7.5 hours of training.
- +3 more other outcomes
Study Arms (1)
Hands-free exoskeleton
EXPERIMENTALInterventions
Before the simulated-use test, the SCI user and his/her companion must attend five training sessions provided by a Wandercraft certified trainer. Training will be composed by a theoretical part including presentation and description of the personal exoskeleton and its use modes and a hands-on practice. Each session lasts between 1 to 2 hours, varying according to the user's learning pace and tolerance. The training program is representative of the intended training for the end product.
Eligibility Criteria
You may qualify if:
- Any gender, age 18 years old or older.
- Motor complete or incomplete SCI with a clinical presentation of a neurological level at or above T6.
- Has been released from acute inpatient care following their SCI.
- Able and willing to attend 6 one-to-two-hour sessions of training.
- Able to read, understand, and provide informed consent.
- Patients affiliated to a social security system.
You may not qualify if:
- Any neurological injury other than spinal cord injury (SCI), except where such injury does not result in physical disability
- Progressive condition that would be expected to result in changing neurological status.
- Severe concurrent medical disease, illness or condition judged to be contraindicated by the site physician.
- Individual with history of osteoporotic fracture and / or pathology or treatment causing secondary osteoporosis.
- Untreatable severe spasticity judged to be contraindicated by the site physician.
- Untreated/uncontrolled hypertension as judged to be contraindicated by the site physician.
- Unresolved orthostatic hypotension as judged to be contraindicated by the site physician.
- History of uncontrolled autonomic dysreflexia.
- Presence of colostomy and/or urostomy.
- Ventilator use at the time of exoskeleton use.
- Presence of life supporting device (e.g., pacemaker).
- Open or unhealed skin pressure sores, abrasions, or bruises at any of the contact points of the exoskeleton.
- Morphological contraindications to the use of the device.
- Uncorrectable leg length discrepancy over 2 cm (about 0.79 in) when using additional correction tools.
- Individuals with functional and/or cognitive impairments that prevent them from effectively operating the device using a hand control interface.
- +13 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wandercraftlead
Study Sites (1)
Wandercraft
Paris, 75004, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rebecca Sauvagnac, MD
Wandercraft
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2024
First Posted
December 4, 2024
Study Start
August 20, 2024
Primary Completion
October 31, 2024
Study Completion
October 31, 2024
Last Updated
December 4, 2024
Record last verified: 2024-12